Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Celator Pharmaceuticals, Inc.

Home Clinical Trial Sponsors and OrganizationsCelator Pharmaceuticals, Inc.

Celator Pharmaceuticals, Inc.

ACTIVE

新泽西州默瑟县, New Jersey, United Stateswww.celatorpharma.comSubsidiary25 employeesEstablished: 1999-01-01

Part of 爵士制药

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

1

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1999

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

Active, not recruiting

1

100.0%

Clinical Trials

Trials sponsored by this organization (1)

Phase IIB, multicenter, randomized, open-label trial of CPX-351 (Cytarabine:Daunorubicin) liposome injection versus intensive salvage therapy in adult patients = 60 years old with AML in first relapse following an initial CR > 1 month duratio

Active, not recruiting

Aug 2009120 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials1
Approvals
News

Back to Organizations